GlaxoSmithKline (GSK) has submitted an application to Health Canada seeking approval of its chronic hepatitis B therapy bepirovirsen…
Marisa Horak, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Horak, MS
FATTY LIVER DISEASE
NewsMadrigal Pharmaceuticals expands MASH pipeline with genetic treatment
Madrigal Pharmaceuticals has secured worldwide rights to develop ARO-PNPLA3, an experimental treatment created by Arrowhead Pharmaceuticals for people…
BILIARY ATRESIA
NewsCMV marker in bile duct cells tied to worse biliary atresia outcomes
Children with biliary atresia who had evidence of active cytomegalovirus (CMV) infection involving bile duct cells in the liver…
HEPATITIS
NewsAdvocates push for testing during Hepatitis Awareness Month
May is Hepatitis Awareness Month, and advocates are working to spread the word about viral hepatitis — a group…
Investing in hepatitis C testing and treatment may actually lower healthcare costs over time, according to a new study…
FATTY LIVER DISEASE
NewsDosing starts in Phase 2 trial of oral therapy HU6 for MASH
A Phase 2 clinical trial testing Rivus Pharmaceuticals‘ experimental oral therapy HU6 in people with metabolic dysfunction-associated steatohepatitis (MASH),…
FATTY LIVER DISEASE
NewsNew ALF board chair turned personal loss from MASH into public advocacy
David Frank, who lost his mother to a severe form of steatotic liver disease and has since become a…
April is officially recognized in the U.S. as National Donate Life Month, an opportunity to highlight the extraordinary impact of…
CHOLESTASIS
NewsInflammation markers may predict fetal risk in ICP: Study
Blood levels of certain pro-inflammatory proteins are elevated in people with intrahepatic cholestasis of pregnancy (ICP), and these inflammatory…
An artificial intelligence (AI) tool that analyzes patterns in blood molecules may help distinguish people with primary sclerosing cholangitis…